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AbstrAct
Objectives Recently, the density score of coronary artery calcium (CAC) has been shown to be associated with a lower risk of cardiovascular disease (CVD) events at any level of CAC volume. Whether risk factors for CAC volume and CAC density are similar or distinct is unknown. We sought to evaluate the associations of CVD risk factors with CAC volume and CAC density scores. Methods Baseline measurements from 6814 participants free of clinical CVD were collected for the Multi-Ethnic Study of Atherosclerosis. Participants with detectable CAC (n=3398) were evaluated for this study. Multivariable linear regression models were used to evaluate independent associations of CVD risk factors with CAC volume and CAC density scores. results Whereas most CVD risk factors were associated with higher CAC volume scores, many risk factors were associated with lower CAC density scores. For example, diabetes was associated with a higher natural logarithm (ln) transformed CAC volume score (standardised β=0.44 (95% CI 0.31 to 0.58) ln-units) but a lower CAC density score (β=−0.07 (−0.12 to −0.02) density units). Chinese, African-American and Hispanic race/ethnicity were each associated with lower ln CAC volume scores (β=−0.62 (−0.83to −0.41), −0.52 (−0.64 to −0.39) and −0.40 (−0.55 to −0.26) ln-units, respectively) and higher CAC density scores (β= 0.41 (0.34 to 0.47), 0.18 (0.12 to 0.23) and 0.21 (0.15 to 0.26) density units, respectively) relative to non-Hispanic White. conclusions In a cohort free of clinical CVD, CVD risk factors are differentially associated with CAC volume and density scores, with many CVD risk factors inversely associated with the CAC density score after controlling for the CAC volume score. These findings suggest complex associations between CVD risk factors and these components of CAC.
IntrOductIOn
As a marker of underlying coronary artery atherosclerosis, coronary artery calcium (CAC) has been observed to be strongly associated with atherosclerotic cardiovascular disease (CVD) risk. 1 The predominant metric used to quantify CAC is the Agatston score, which is comprised of the two-dimensional area of CAC and a four-point multiplicative factor based on the maximum density within each plaque. 2 Thus, both a greater area of CAC and a higher density of CAC will increase the Agatston score. However, in a prior study from the Multi-Ethnic Study of Atherosclerosis (MESA), a higher average CAC density score was found to be associated with a lower risk of CVD events when adjusted for the CAC volume score. 3 This finding is consistent with studies in the literature that have found sparsely calcified atherosclerotic plaques to more frequently result in coronary events compared with heavily calcified plaques. [4] [5] [6] Taken together, these findings suggest that a higher density of CAC may be associated with lower, rather than higher, CVD risk. 3 These findings also highlight the need to evaluate the associations of CVD risk factors with CAC separated into its components of volume and density. Risk factors for CVD have previously been linked to CAC Agatston scores, 7 8 yet the associations of CVD risk factors with CAC volume and density scores are unknown. Given the apparently opposite associations of CAC volume and density with CVD events, investigating determinants of these CAC components may yield further insight into the relationship between CAC and CVD. Therefore, we aimed to elucidate the associations of CVD risk factors with CAC volume and density scores to further investigate the inverse association of CAC density with CVD risk.
MethOds

MesA study design
The MESA is a prospective cohort study started in July 2000 designed to evaluate subclinical CVD in a multiethnic cohort. The detailed study design has previously been reported. 9 Briefly, community-dwelling individuals aged 45-84 years were recruited from six study sites: Baltimore, Maryland; Chicago, Illinois; Winston-Salem, North Carolina; Los Angeles, California; New York, New York and St. Paul, Minnesota. The study population had an approximate ethnic composition of 38% non-Hispanic White (NHW), 28% African-American, 23% Hispanic and 11% Asian (predominantly Chinese). Participants with any history of clinically apparent CVD or major obstacles to follow-up were excluded. Measurements at the first examination between July 2000 and July 2002 included a participant questionnaire, collection of fasting blood samples and cardiac CT imaging. The institutional 2 These plaque-specific scores were then summed to produce the Agatston score. Results from the duplicate scans of each participant were averaged for final volume and Agatston scores.
The average CAC density score of all defined plaques for each participant was obtained by dividing the Agatston score (Agatston = Area*Density factor) by the total CAC area. CAC area was derived by dividing the CAC volume by the CT scan slice thickness. 3 As the CAC density score can only be determined in participants with identified CAC volume, participants with CAC volume equal to 0 were excluded.
risk factor assessment
Participants completed self-report questionnaires on pertinent health history including tobacco use, alcohol consumption, medical diagnoses, family history of CVD, medication use, typical walking pace, annual income and level of educations. Tobacco use and alcohol consumption were classified as: never, former or current. Body mass index (BMI) was computed as weight (kg)/squared height (m 2 ). Hip and waist circumference were also measured and used to determine the waisthip ratio (WHR). Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) measurements were taken in triplicate after 5 min of rest from the right arm of participants in the seated position with a Dinamap model Pro 100 automated oscillometric sphygmomanometer (Critikon, Tampa, Florida, USA). The average of the latter two measurements was used in analyses.
Venous blood samples were collected from participants after a 12 hours overnight fast and measured for high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, triglycerides, total cholesterol and glucose levels. Diabetes was defined as either fasting glucose levels>125 mg/ dL or use of hypoglycaemic medications or insulin. Gender, age, total cholesterol, HDL, SBP, antihypertensive use and tobacco usage were used to calculate the Global Framingham Risk Score (GFRS).
11 Serum C reactive protein and fibrinogen concentrations were measured using the BN II nephelometer (Dade Behring, Deerfield, Illinois, USA). Serum interleukin-6 (IL-6) concentration was measured using ultrasensitive ELISA (Quantikine HS Human interleukin-6 Immunoassay; R&D Systems, Minneapolis, Minnesota, USA).
statistical analyses
The exposure variables chosen for this analysis were many traditional and non-traditional cardiovascular risk factors captured in the MESA and included age, gender, race/ethnicity, total cholesterol, HDL-C, SBP, DBP, antihypertensive medication use, smoking status and amount, diabetes, statin use, BMI, waist circumference, hip circumference, WHR, GFRS, family history of myocardial infarction (MI), typical walking pace, alcohol consumption status and amount, IL-6, fibrinogen and CRP concentrations. The outcome variables were the CAC volume score and the CAC density score.
The participants were divided into quartiles of CAC volume and density scores. Quartile means and percentages were computed for continuous and categorical exposure variables, respectively. Analyses of covariance were performed to determine associations of exposure variables across quartiles of CAC volume and density scores adjusted for age, gender and the CAC density score (for models evaluating the CAC volume score) or the CAC volume score (for models evaluating the CAC density score). These covariates were standardised to their mean values of 66.4 years, 57% male and 257.9 mm 3 of CAC volume and 2.69 units of CAC density.
Multivariable linear regressions analyses were performed to evaluate the associations of the exposure variables with CAC volume and density scores. For regression analyses, continuous variables were all scaled to SD units. Because CAC volume has a highly skewed distribution, CAC volume scores were log transformed (ie, natural logarithm (ln) volume score) to reduce skewness. First, associations between individual exposure variables and CAC volume and density scores were adjusted for age, gender and CAC volume or density scores, henceforth referred to as 'minimally adjusted' regression models. Next, we created an intermediate multivariable model incorporating all exposure variables. Then, exposure variables found in the 2013 ACC/AHA ASCVD Pooled Cohort Equations, 12 statin use and any exposure variables with p<0.10 in the intermediate models were forced into the final 'fully-adjusted' multivariable models. The exposure variables included in both CAC volume and density final models were age, gender, race/ ethnicity, annual income, total cholesterol, HDL, SBP, smoking status, diabetes status, antihypertensive use, statin use, BMI, walking pace and IL-6. Level of education, family history of MI, alcohol consumption amount and CRP were also included in the final CAC volume model. Variables excluded from both final models were smoking amount, hip circumference, waist circumference, WHR, alcohol consumption status and fibrinogen.
β-Coefficients for continuous variables are per SD change in the exposure variable. All statistical analyses were performed in SPSS version 22 (IBM, Armonk, New York, USA). Statistical significance was defined as a two-tailed p value of less than 0.05.
results
Of the 6814 MESA participants, 3398 had CAC volume scores>0 and were retained in the analysis. Only those variables previously shown to be strongly tied to CVD risk (ie, components of the pooled cohort equations and statin use) and any others that yielded p<0.10 were included in the final fully adjusted multivariable model, shown on the right. BMI, body mass index; BP, blood pressure; CAC, coronary artery calcium; CRP, C reactive protein; CVD, cardiovascular disease; HDL, high-density lipoprotein; IL-6, interleukin-6; ln, natural log; MI, myocardial infarction; WHR, waist-hip ratio. Table 2 displays the cohort characteristics stratified by quartiles of ascending CAC density scores. Across ascending quartiles, the proportion of Chinese increased monotonically, whereas NHW decreased monotonically. Family history of MI, BMI, waist circumference, the GFRS, CRP and IL-6 decreased monotonically across increasing quartiles. Table 3 displays the associations of CVD risk factors with ln CAC volume score in minimally adjusted and fully adjusted multivariable regression models, which included adjustment for the CAC density score. The adjusted R 2 for the fully adjusted model was 0.49. The CAC density score was positively associated with the ln CAC volume score (β=0.94 ln-units, fully adjusted model). Compared with NHW, the other three races/ethnicities were each significantly associated with a lower ln CAC volume score and had the strongest inverse associations (β=−0.62,-0.52 and −0.40 ln-units for Chinese, African-American and Hispanic, respectively, fully adjusted model). Age, male gender, college or greater level of education, total cholesterol, diabetes, antihypertensive medication use, BMI, family history of MI and amount of alcohol consumption were all positively associated with the ln CAC volume score. Annual income greater than $100 000, average and brisk walking paces and CRP were inversely associated with the ln CAC volume score. Table 4 shows associations of risk factors with CAC density in minimally adjusted and fully adjusted multivariable models. The adjusted R 2 for the fully adjusted model was 0.41. The ln CAC volume score was positively associated with the CAC density score (β=0.44 density units). With NHW as the reference, race/ethnicity variables were among the strongest positive correlates of the CAC density score (β=0.41, 0.18, 0.21 density units for Chinese, African-American and Hispanic, respectively, fully adjusted model). Age, annual income greater than $100 000, HDL-C and brisk walking pace were positively associated with the CAC density score, while male gender, diabetes and BMI were inversely associated with the CAC density score.
Compared with no walking, stroll, average pace and stride had borderline positive associations with the CAC density score in the fully adjusted model that were not statistically significant. Total cholesterol and systolic BP had borderline inverse associations with the CAC density score in the fully adjusted model that were not statistically significant. Figure 1 graphically summarises the magnitude and direction of the associations between CVD risk factors and CAC volume and CAC density scores. β-coefficients from the fully adjusted multivariable regression models are plotted. For risk factors retained in the multivariable models, the associations for volume and density scores tended to be in opposite directions. The associations for race/ethnicity were as strong or stronger than most of the traditional risk factor associations.
dIscussIOn
In a large, multiethnic cohort of community-living individuals with detectable CAC who were free of clinical CVD, we found that many CVD risk factors were generally associated with CAC volume and CAC density scores in opposite directions. For instance, diabetes and higher BMI were associated with higher CAC volume but lower CAC density scores. Moreover, HDL-C, a risk factor known to be inversely associated with coronary heart disease risk 13 and faster walking paces were associated with a higher CAC density score. These observations align with previous findings from this cohort demonstrating that a higher CAC density score is associated with a lower risk of CVD events at any level of CAC volume. 3 Taken together, CAC density appears to be a quantifiable aspect of CAC that is inversely associated with CVD risk factors and CVD events, despite the strong overall association of CAC with subclinical coronary artery disease. While CVD risk factors appeared to have relatively stronger associations with CAC volume scores than CAC density scores among individuals with calcified atherosclerosis, Coefficients for ln CAC volume and CAC density scores cannot be quantitatively compared due to inherent unit differences between measurements of CAC volume and CAC density scores. coronary artery disease a higher CAC density score may nonetheless be a marker of a more favourable CVD risk factor profile.
We also found striking associations between race/ethnicity and CAC volume and density scores. Specifically, NHW participants showed higher CAC volume and lower CAC density scores compared with the other race/ethnicity groups after multivariable adjustment. The distribution of CAC as quantified by the Agatston score has previously been observed to vary significantly by race/ethnicity in this cohort.
14 Race/ethnicity may influence the development of CAC through its volume and density components, and this may merit further investigation.
Our findings also support the observation that the Agatston scoring method of weighting CAC scores to account for higher CAC density may be suboptimal. Several studies have demonstrated the associations of CVD risk factors with higher CAC Agatston scores, 7 8 15 but to our knowledge no previous study has differentiated CVD risk factor associations with CAC volume and CAC density independently. As many CVD risk factors were associated with a lower CAC density score, it appears that the Agatston score may obscure important associations between CVD risk factors and CAC composition.
In this observational study, the associations of statin use with CAC volume and density scores were not statistically significant. Clinical trials have suggested that statins do not attenuate (and may actually increase) the progression of CAC. [16] [17] [18] In a recent meta-analysis of eight randomised clinical trials, statins appeared to increase calcified plaque while decreasing non-calcified plaque in coronary arteries assessed with intravascular ultrasound. 19 Our findings may be distorted due to confounding by indication, as participants prescribed statins tend to have a greater burden of CVD risk factors. Furthermore, annual income was found to have a positive association with CAC density and an inverse association with CAC volume. These observations suggest that there may be additional factors not captured in the models that influence CAC volume and density.
Among the strengths of this study are its large sample size, broad range of CVD risk factors and the multiethnic nature of the study population. The study also has important limitations. First, the density score does not measure the density of individual plaques, but rather an average of all calcified plaques identified in the coronary tree. The density score is arbitrarily capped at a maximum of four for all plaque densities greater than 400 Hu, potentially attenuating the inverse association of CVD risk factors with CAC density. Adults with clinical CVD at baseline were excluded from participating in the MESA, and participants without detectable CAC (and thus no density score) were excluded from this analysis by necessity; as such, the study sample was middle aged and had detectable CAC but no clinically apparent CVD. Whether results will generalise to other populations is presently uncertain. Finally, in multiple linear regression models reporting the associations of several exposure variables with the outcomes of CAC volume and density scores, some of the significant associations observed may have been due to chance as a consequence of multiple testing.
In conclusion, we demonstrated the differential associations of CVD risk factors with CAC volume and density scores. CVD risk factors were generally associated with higher CAC volume scores, but some CVD risk factors were also associated with lower CAC density scores. NHW race was also strongly associated with higher CAC volume but lower CAC density scores. These findings suggest a complex association between CVD risk factors and CAC volume and density components, and highlight a limitation of the Agatston method of CAC scoring. Future studies should address whether modification of CVD risk factors might have a dual effect of reducing CAC volume and increasing CAC density.
Key messages
What is already known on this subject? Coronary artery calcium (CAC) is a robust marker of subclinical cardiovascular disease (CVD). Recently, the density score of CAC has been shown to be inversely associated with CVD events after adjusting for the CAC volume score. Determinants of the CAC density score are unknown.
What might this study add?
This study demonstrates that many demographic and CVD risk factors tend to have opposite associations with CAC volume and density scores, with many CVD risk factors being inversely associated with the CAC density score.
how might this impact on clinical practice? As favourable risk factor profiles among individuals with detectable CAC appear to be associated with a higher CAC density score, assessment of the CAC density score may provide additional insight into an individual's overall risk of CVD.
